The role of stem cells in lymphangiogenesis was first described by Liersch et al. [26] by use of embryonic stem cells stimulated with both VEGF-C and VEGF-A, but, since then, only few reports on the potential role of stem cells for treatment of lymphedema can be found [16, 27–29]. The gene discussed is VEGFC; the disease is lymphedema.